{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06525740",
            "orgStudyIdInfo": {
                "id": "24-001383"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2024-06145",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "24-001383",
                    "type": "OTHER",
                    "domain": "Mayo Clinic in Rochester"
                }
            ],
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery",
            "officialTitle": "Methadone Versus Intrathecal Hydromorphone for Postoperative Analgesia in Patients Undergoing Surgery for Gynecologic Malignancy Via Midline Laparotomy Receiving Liposomal Bupivacaine",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "methadone-versus-intrathecal-hydromorphone-for-postoperative-pain-relief-in-gynecologic-cancer-undergoing-surgery"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-09-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-09-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-09-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-24",
            "studyFirstSubmitQcDate": "2024-07-24",
            "studyFirstPostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This phase IV trial compares methadone versus hydromorphone given in the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord (intrathecal) for postoperative pain relief in patients with gynecologic cancer undergo surgery. Methadone binds to opioid receptors in the central nervous system and is a long-acting opioid pain medication. Intrathecal hydromorphone works by changing the way the brain and nervous system respond to pain and is similar to an epidural. This trial may help researchers determine if methadone works as well as intrathecal hydromorphone for pain relief after surgery in patients with gynecologic cancer.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. To determine whether intravenous methadone can provide comparable analgesia to an intrathecal injection of hydromorphone.\n\nOUTLINE: Patients are randomized to 1 of 2 arms.\n\nARM I: Patients receive methadone intravenously (IV) during induction of general anesthesia for standard of care (SOC) surgery.\n\nARM II: Patients receive hydromorphone intrathecally (IT) prior to induction of general anesthesia for SOC surgery.\n\nAfter completion of study intervention, patients are followed up at 1 month."
        },
        "conditionsModule": {
            "conditions": [
                "Malignant Female Reproductive System Neoplasm"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 140,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm I (methadone)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive methadone IV during induction of general anesthesia for SOC surgery.",
                    "interventionNames": [
                        "Drug: Methadone",
                        "Other: Questionnaire Administration"
                    ]
                },
                {
                    "label": "Arm II (hydromorphone)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive hydromorphone IT prior to induction of general anesthesia for SOC surgery.",
                    "interventionNames": [
                        "Drug: Hydromorphone",
                        "Other: Questionnaire Administration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Hydromorphone",
                    "description": "Given IT",
                    "armGroupLabels": [
                        "Arm II (hydromorphone)"
                    ],
                    "otherNames": [
                        "(-)-Hydromorphone",
                        "Dihydromorphinone",
                        "Hydromorphon"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Methadone",
                    "description": "Given IV",
                    "armGroupLabels": [
                        "Arm I (methadone)"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Questionnaire Administration",
                    "description": "Ancillary studies",
                    "armGroupLabels": [
                        "Arm I (methadone)",
                        "Arm II (hydromorphone)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Difference in pain scores",
                    "description": "Will be assessed per group \\[intravenous (IV) methadone or intrathecal (IT) hydromorphone\\] by patient-reported pain on a scale of 0-10 where 0=no pain and 10=worst pain imaginable.",
                    "timeFrame": "Baseline, upon leaving post-anesthesia care unit (PACU), and at 4, 8, and 12 hours, up to 24 hours postoperatively"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Morphine milligram equivalents",
                    "description": "Will be assessed by the number of morphine milligram equivalents utilized for the first 24 hours postoperatively.",
                    "timeFrame": "Up to 24 hours postoperatively"
                },
                {
                    "measure": "Incidence of itching",
                    "description": "Will be assessed by the number of patients patient-reported itching on follow-up visits.",
                    "timeFrame": "Up to 24 hours postoperatively"
                },
                {
                    "measure": "Incidence of respiratory depression",
                    "description": "Will be assessed by the number of patients who experience incidents of respiratory depression, defined breathing less frequently as a result of opioid administration.",
                    "timeFrame": "Up to 24 hours postoperatively"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Undergoing surgery with a laparotomy for gynecologic malignancy\n* Planned inpatient admission greater than 24 hours\n\nExclusion Criteria:\n\n* Chronic pain requiring opioid medications as an outpatient\n* Prolonged corrected QT interval (QTc) \\> 480ms\n* Chronic kidney disease with estimated glomerular filtration rate (eGFR) \\< 30 milliliters per minute (mL/min)\n* Documented cirrhosis\n* Preoperative platelets (PLT) \\< 75\n* Preoperative international normalized ratio (INR) \\> 1.5\n* Inappropriate cessation of anticoagulation medications prior to surgery\n* Intolerance to hydromorphone or methadone\n* Contraindication to administration of liposomal bupivacaine\n* Subsequent surgeries after index surgery",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials Referral Office",
                    "role": "CONTACT",
                    "phone": "855-776-0015",
                    "email": "mayocliniccancerstudies@mayo.edu"
                },
                {
                    "name": "Karen Ishitani, R.N.",
                    "role": "CONTACT",
                    "phone": "507-538-5355",
                    "email": "Ishitani.Karen@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Sean C. Dowdy, M.D.",
                    "affiliation": "Mayo Clinic in Rochester",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Trials Referral Office",
                            "role": "CONTACT",
                            "phone": "855-776-0015",
                            "email": "mayocliniccancerstudies@mayo.edu"
                        },
                        {
                            "name": "Karen Ishitani, R.N.",
                            "role": "CONTACT",
                            "phone": "507-538-5355",
                            "email": "Ishitani.Karen@mayo.edu"
                        },
                        {
                            "name": "Sean C. Dowdy, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13069",
                    "name": "Pain, Postoperative",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "asFound": "Female Reproductive System Neoplasm",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008691",
                    "term": "Methadone"
                },
                {
                    "id": "D000004091",
                    "term": "Hydromorphone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000701",
                    "term": "Analgesics, Opioid"
                },
                {
                    "id": "D000009294",
                    "term": "Narcotics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000000996",
                    "term": "Antitussive Agents"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M5315",
                    "name": "Bupivacaine",
                    "relevance": "LOW"
                },
                {
                    "id": "M11671",
                    "name": "Methadone",
                    "asFound": "NaCl",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7275",
                    "name": "Hydromorphone",
                    "asFound": "Package",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M12245",
                    "name": "Narcotics",
                    "relevance": "LOW"
                },
                {
                    "id": "M13570",
                    "name": "Phenylpropanolamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M9238",
                    "name": "Guaifenesin",
                    "relevance": "LOW"
                },
                {
                    "id": "M186319",
                    "name": "Chlorpheniramine, phenylpropanolamine drug combination",
                    "relevance": "LOW"
                },
                {
                    "id": "M4312",
                    "name": "Antitussive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "AnTuAg",
                    "name": "Antitussive Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "AnObAg",
                    "name": "Anti-Obesity Agents"
                },
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                }
            ]
        }
    },
    "hasResults": false
}